more...
more...
Jentech Precision Industrial Co., Ltd. completed a successful initial public offering.
COXON Precise Industrial Co., Ltd. completed a successful initial public offering.
Hi-Clearance Inc. completed a successful initial public offering.
Merck & Co., Inc. and Portola Enter Worldwide License Agreement to Develop and Commercialize Betrixaban, a Novel Investigational Oral Anticoagulant for Cardiovascular Disease.
Bayhill Therapeutics Enters Exclusive, Worldwide Collaboration with Genentech for BHT-3021 in Type 1 Diabetes.
About Us  ∣  Team  ∣  Portfolio  ∣  News  ∣  Contact Us

Copyright 2000-2008 PAC-LINK Management Corp.  All rights reserved. Various trademarks held by their respective owners.